20-F: Haoxi Health Technology Limited Files 20-F Annual Report, Details Financials and Operational Risks
Annual Report
Haoxi Health Technology Limited files its 20-F annual report, outlining its financial performance, business operations, and associated risks, particularly those related to operating in China.
Summary
- Haoxi Health Technology Limited, a Cayman Islands holding company, conducts its operations in China through its subsidiary, Haoxi Beijing, an online marketing solution provider primarily serving the healthcare industry.
- The company's revenue is generated by providing one-stop online marketing solutions, especially short video ads, to advertisers through media partners.
- Haoxi completed its IPO on January 26, 2024, raising $11.04 million in gross proceeds, and a follow-on offering on September 20, 2024, generating $12.0 million in gross proceeds.
- The company faces legal and operational risks associated with operating in China, including regulatory uncertainties and potential interventions by the PRC government.
- For the fiscal year ended June 30, 2024, Haoxi reported revenue of $48.52 million and net income of $1.29 million.
- The company identifies material weaknesses in its internal controls over financial reporting (ICFR) and is taking remedial measures.
- The company's Class A Ordinary Shares are subject to market volatility and potential delisting under the Holding Foreign Companies Accountable Act (HFCA Act) if the PCAOB cannot inspect its auditors for two consecutive years.
Sentiment
Score: 5
Explanation: The document presents a mixed sentiment. While the company shows revenue growth and completed successful capital raises, it also faces significant risks related to operating in China, regulatory uncertainties, and material weaknesses in its internal controls.
Positives
- The company's revenue increased by 72% to $48.52 million for the fiscal year ended June 30, 2024.
- The company reported a net income of $1.29 million for the fiscal year ended June 30, 2024.
- The company has a growing advertiser base, serving 543 customers in fiscal year 2024.
- The company has developed its own data analysis software, Bidding Compass, to improve ad placement efficiency.
- The company has established relationships with mainstream media platforms in China.
Negatives
- The company faces legal and operational risks associated with operating in China, including regulatory uncertainties and potential interventions by the PRC government.
- The company identifies material weaknesses in its internal controls over financial reporting (ICFR).
- The company is exposed to concentration risk due to its reliance on Ocean Engine for a significant portion of its ad placements.
- The company may be treated as a resident enterprise for PRC tax purposes, subjecting it to PRC income tax on its global income.
- The company may face difficulties in effecting service of legal process, enforcing foreign judgments, or bringing actions in China against the company or its management.
Risks
- Changes in PRC government policies and regulations could adversely affect the company's business.
- Uncertainties exist regarding the interpretation and enforcement of PRC laws.
- The PRC government may intervene or influence the company's operations at any time.
- The company's Class A Ordinary Shares may be prohibited from trading on a national exchange under the HFCA Act if the PCAOB is unable to inspect its auditors for two consecutive years.
- Restrictions on currency exchange may limit the company's ability to utilize its revenue effectively.
- The company may experience net cash outflow from operating activities.
- The company is exposed to concentration risk due to its reliance on Ocean Engine.
- The trading price of the company's Class A Ordinary Shares is likely to be volatile.
Future Outlook
The company intends to use the proceeds from its offerings for working capital, general corporate purposes, acquiring or investing in technologies, solutions, or businesses that complement its business, and hiring experienced employees to improve its systems of internal control and compliance with U.S. GAAP and the Sarbanes-Oxley Act of 2002.
Industry Context
The company operates in the competitive online marketing industry in China, which is rapidly evolving due to technological advancements and changing consumer demands. The company's growth is influenced by the increasing adoption of news feed ads and the rapid development of the healthcare industry in China.
Comparison to Industry Standards
- The document does not provide specific comparisons to industry standards or competitors.
- However, it mentions that the company competes with other online advertising service providers in China on factors such as brand recognition, quality of services, pricing, and strategic relationships.
- The document also notes that the company's growth has benefited from the quick increase of news feed ads in the online marketing industry in China.
Related Party Transactions
- The company had amounts due to a related party, Zhen Fan, of $6,187 and $20,210 as of June 30, 2024 and 2023, respectively, representing advances provided by the CEO.
Stakeholder Impact
- Shareholders face risks related to market volatility, potential delisting, and regulatory uncertainties.
- Employees may be affected by changes in compensation, potential disciplinary actions for violating insider trading policies, and the company's ability to provide benefits.
- Customers may be affected by the company's ability to provide effective online marketing solutions and maintain relationships with media partners.
- Suppliers may be affected by the company's financial condition and ability to make payments.
- Creditors face risks related to the company's ability to repay its debts.
Next Steps
- The company plans to continue to implement measures to remediate the material weaknesses in its ICFR.
- The company intends to use the proceeds from its offerings for working capital, general corporate purposes, acquiring or investing in technologies, solutions, or businesses that complement its business, and hiring experienced employees to improve its systems of internal control and compliance with U.S. GAAP and the Sarbanes-Oxley Act of 2002.
Key Dates
| Date | Description |
|---|---|
| 2018-09-26 | Haoxi Beijing incorporated |
| 2019-03-15 | PRC Foreign Investment Law approved |
| 2020-01-01 | PRC Foreign Investment Law came into effect |
| 2023-02-17 | CSRC released the Overseas Listing Trial Measures |
| 2023-03-31 | Overseas Listing Trial Measures came into effect |
| 2024-01-26 | Haoxi Class A Ordinary Shares began trading on Nasdaq |
| 2024-01-30 | Haoxi closed its initial public offering (IPO) |
| 2024-03-08 | Underwriter exercised over-allotment option in full |
| 2024-06-30 | End of fiscal year |
| 2024-09-20 | Haoxi closed its follow-on offering |
Keywords
online marketing, healthcare industry, China, financial results, risk factors, 20-F, Haoxi Health Technology, advertising, regulatory, CSRC, PCAOB
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.